pFUSEss-CHIg-mM_M18
(Plasmid
#91729)
-
PurposeExpression plasmid coding for heavy chain of mouse IgM antibody specific to antigen B of the ABO blood group system, clone M18.
-
Depositing Lab
-
Sequence Information
-
Sequences (1) — Accept Affinity Reagent Sequence Policy
-
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 91729 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepFUSEss-CHIg-mM
-
Backbone manufacturerInvivogen
- Backbone size w/o insert (bp) 4852
- Total vector size (bp) 5219
-
Vector typeMammalian Expression
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Bleocin (Zeocin), 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsTop10 or DH5alpha could be selected on LB LOW SALT with 35-50 micrograms/ml Zeocin.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameimmunoglobulin heavy constant mu
-
Alt nameIgM, IGHM, mouse IgM (immunoglobulin M) heavy chain
-
SpeciesM. musculus (mouse)
-
Insert Size (bp)367
-
GenBank ID16019
-
Entrez GeneIghm (a.k.a. Igh-6, Igh-M, Igh6, Igm, muH)
- Promoter hEF1-HTLV prom
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site NheI (not destroyed)
- 5′ sequencing primer RVprimer3
- 3′ sequencing primer EBV-rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pFUSEss-CHIg-mM_M18 was a gift from Joanna Bereta (Addgene plasmid # 91729 ; http://n2t.net/addgene:91729 ; RRID:Addgene_91729) -
For your References section:
Mouse Antibody of IgM Class is Prone to Non-Enzymatic Cleavage between CH1 and CH2 Domains. Klaus T, Stalinska K, Czaplicki D, Mak P, Skupien-Rabian B, Kedracka-Krok S, Wiatrowska K, Bzowska M, Machula M, Bereta J. Sci Rep. 2018 Jan 11;8(1):519. doi: 10.1038/s41598-017-19003-4. 10.1038/s41598-017-19003-4 PubMed 29323348